Congenital dilated pupil warrants instant investigation

Article

The rare disease multisystemic smooth muscle dysfunction syndrome has a serious outcome

Gene mutation

The condition, caused by the mutation of the ACTA2 gene, is multisystemic smooth muscle dysfunction syndrome, which Dr Møller and colleagues investigated in three Danish children.1 "When we saw the first patient 15 years ago, we thought that the diagnosis was a variant of aniridia and the important thing to do would be to exclude the WAGR association and the risk of Wilms tumour," he continued. "However, this was not the case. We later discovered a lack of accommodation, a dilated aorta and cerebral signs and symptoms from vessel pathology in the brain and thus we realised the common pathophysiology had to be the smooth muscles."

Results and discussion

The occurrence of serious vascular and cardiac problems are not uncommon, he noted. "One of our patients died as a young teenager and one had a neurosurgical procedure for intra cerebral infarction. Furthermore, I have heard from colleagues abroad who saw similar cases that one of their young patients also died," he said.

"In fact, after publication of our cases, it has actually become apparent that the oldest patient has developed further changes in the retinal circulation. Therefore, it is mandatory to follow these patients in a medical retina clinic. This serious, life threatening disease, even though it is a very rare condition, needs urgent attention," he concluded.

Special contributor

Hans Ulrik Møller PhD, is a consultant ophthalmologist, paediatric ophthalmology at the Viborg/Aarhus Hospitals, Denmark. He can be contacted by Email: Hans.ulrik.moeller@viborg.rm.dk

Dr Møller has indicated that he has no financial disclosures relating to the content of this piece.

Reference

1. H.U. Møller et al., Br. J. Ophthalmol., 2012;96:1227–1231.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
3 experts are featured in this series.
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Related Content
© 2025 MJH Life Sciences

All rights reserved.